» Articles » PMID: 35860250

Obesity, Inflammation, and Immune System in Osteoarthritis

Overview
Journal Front Immunol
Date 2022 Jul 21
PMID 35860250
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity remains the most important risk factor for the incidence and progression of osteoarthritis (OA). The leading cause of OA was believed to be overloading the joints due to excess weight which in turn leads to the destruction of articular cartilage. However, recent studies have proved otherwise, various other factors like adipose deposition, insulin resistance, and especially the improper coordination of innate and adaptive immune responses may lead to the initiation and progression of obesity-associated OA. It is becoming increasingly evident that multiple inflammatory cells are recruited into the synovial joint that serves an important role in pathological changes in the synovial joint. Polarization of macrophages and macrophage-produced mediators are extensively studied and linked to the inflammatory and destructive responses in the OA synovium and cartilage. However, the role of other major innate immune cells such as neutrophils, eosinophils, and dendritic cells in the pathogenesis of OA has not been fully evaluated. Although cells of the adaptive immune system contribute to the pathogenesis of obesity-induced OA is still under exploration, a quantity of literature indicates OA synovium has an enriched population of T cells and B cells compared with healthy control. The interplay between a variety of immune cells and other cells that reside in the articular joints may constitute a vicious cycle, leading to pathological changes of the articular joint in obese individuals. This review addresses obesity and the role of all the immune cells that are involved in OA and summarised animal studies and human trials and knowledge gaps between the studies have been highlighted. The review also touches base on the interventions currently in clinical trials, different stages of the testing, and their shortcomings are also discussed to understand the future direction which could help in understanding the multifactorial aspects of OA where inflammation has a significant function.

Citing Articles

Identification of Energy Metabolism-Related Subtypes and Diagnostic Biomarkers for Osteoarthritis by Integrating Bioinformatics and Machine Learning.

Xu S, Ye J, Cai X J Multidiscip Healthc. 2025; 18:1353-1369.

PMID: 40060994 PMC: 11890432. DOI: 10.2147/JMDH.S510308.


Global, regional, and national epidemiology of osteoarthritis in working-age individuals: insights from the global burden of disease study 1990-2021.

Ma W, Chen H, Yuan Q, Chen X, Li H Sci Rep. 2025; 15(1):7907.

PMID: 40050342 PMC: 11885640. DOI: 10.1038/s41598-025-91783-6.


Specific gut microbiota and serum metabolite changes in patients with osteoarthritis.

Wang W, Liu X, Nan H, Li H, Yan L Front Cell Dev Biol. 2025; 13:1543510.

PMID: 40027098 PMC: 11868077. DOI: 10.3389/fcell.2025.1543510.


ITGB5 as a Potential Diagnostic Biomarker for Osteoarthritis.

Hu S, Huang J, Wang W J Musculoskelet Neuronal Interact. 2025; 25(1):86-100.

PMID: 40024232 PMC: 11880847. DOI: 10.22540/JMNI-25-086.


Extracecellulr vesicles (EVs) microRNAs (miRNAs) derived from mesenchymal stem cells (MSCs) in osteoarthritis (OA); detailed role in pathogenesis and possible therapeutics.

Pakdaman Kolour S, Nematollahi S, Dehbozorgi M, Fattahi F, Movahed F, Esfandiari N Heliyon. 2025; 11(3):e42258.

PMID: 40007782 PMC: 11850152. DOI: 10.1016/j.heliyon.2025.e42258.


References
1.
Moradi B, Schnatzer P, Hagmann S, Rosshirt N, Gotterbarm T, Kretzer J . CD4⁺CD25⁺/highCD127low/⁻ regulatory T cells are enriched in rheumatoid arthritis and osteoarthritis joints--analysis of frequency and phenotype in synovial membrane, synovial fluid and peripheral blood. Arthritis Res Ther. 2014; 16(2):R97. PMC: 4060198. DOI: 10.1186/ar4545. View

2.
Wentworth J, Naselli G, Brown W, Doyle L, Phipson B, Smyth G . Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes. 2010; 59(7):1648-56. PMC: 2889764. DOI: 10.2337/db09-0287. View

3.
Zuniga L, Shen W, Joyce-Shaikh B, Pyatnova E, Richards A, Thom C . IL-17 regulates adipogenesis, glucose homeostasis, and obesity. J Immunol. 2010; 185(11):6947-59. PMC: 3001125. DOI: 10.4049/jimmunol.1001269. View

4.
Sekar S, Shafie S, Prasadam I, Crawford R, Panchal S, Brown L . Saturated fatty acids induce development of both metabolic syndrome and osteoarthritis in rats. Sci Rep. 2017; 7:46457. PMC: 5394476. DOI: 10.1038/srep46457. View

5.
SantaCruz-Calvo S, Bharath L, Pugh G, SantaCruz-Calvo L, Lenin R, Lutshumba J . Adaptive immune cells shape obesity-associated type 2 diabetes mellitus and less prominent comorbidities. Nat Rev Endocrinol. 2021; 18(1):23-42. PMC: 11005058. DOI: 10.1038/s41574-021-00575-1. View